Alternative Data for Cardiol Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark | |
|---|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up | |
| Sentiment | 73 | Sign up | Sign up | Sign up | |
| Webpage traffic | 12,000 | Sign up | Sign up | Sign up | |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up | |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
| Stocktwits Mentions | 23 | Sign up | Sign up | Sign up | |
| Stocktwits Subscribers | 5,687 | Sign up | Sign up | Sign up | |
| X Followers | 4,871 | Sign up | Sign up | Sign up | |
| X Mentions | 5 | Sign up | Sign up | Sign up | |
| News Mentions | N/A | Sign up | Sign up | Sign up | |
| Customer reviews | N/A | Sign up | Sign up | Sign up | |
| Linkedin Employees | 27 | Sign up | Sign up | Sign up |
About Cardiol Therapeutics
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
| Price | $1.00 |
| Target Price | Sign up |
| Volume | 166,610 |
| Market Cap | $104M |
| Year Range | $0.93 - $1.54 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Drug Manufacturers |
In the news
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 0 | 0 | 0 | -10M | -9.9M | -0.120 |
| Q2 '25 | 0 | 0 | 0 | -8.4M | -7.7M | -0.072 |
| Q1 '25 | 0 | 0 | 0 | -8.3M | -8.4M | -0.100 |
| Q4 '24 | 0 | 34,000 | -34,000 | -5.7M | -5.6M | -0.090 |
| Q3 '24 | 0 | 0 | 0 | -13M | -14M | -0.180 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
![]() |
Johnson & JohnsonJNJ |
$224.44 1.3% | 44 |
![]() |
Eli Lilly and CompanyLLY |
$1039.51 2.2% | 62 |
![]() |
PfizerPFE |
$26.5 2.4% | 51 |
![]() |
AstrazenecaAZN |
$95.6 1.5% | 49 |
![]() |
AbbVieABBV |
$223.93 1.4% | 53 |
Read more about Cardiol Therapeutics (CRDL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews & linkedin employees.
FAQ - Cardiol Therapeutics
The Market Cap of Cardiol Therapeutics is $104M.
Currently, the price of one share of Cardiol Therapeutics stock is $1.00.
The CRDL stock price chart above provides a comprehensive visual representation of Cardiol Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cardiol Therapeutics shares. Our platform offers an up-to-date CRDL stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Cardiol Therapeutics (CRDL) does not offer dividends to its shareholders. Investors interested in Cardiol Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Cardiol Therapeutics are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.




